健康保险公司面临一年严格审查
A year of scrutiny for health insurers
生物技术与制药领域的最新动态
A year of scrutiny for health insurers
ACIP delays vote on hepatitis B birth dose to Friday
Why 10x Genomics Inc. stock appeals to analysts - July 2025 Reactions & Low Risk Entry Point Guides - Newser
CDC panel again postpones vote on newborns’ hepatitis B shot
FDA slaps hold on Denali's plans for phase 1 rare disease trial
GE HealthCare, Mayo Clinic launch digital twin project for personalizing radiation cancer therapy
Paradigm Health raises $78M to revamp clinical research process, inks deal with Roche’s Flatiron
How Lonza Group AG (Common Stock) (LO31) stock trades in high volatility - July 2025 News Drivers & Daily Technical Forecast Reports - Newser
What MACD trends signal for Lonza Group AG (Common Stock) (LO3A) stock - Trade Volume Summary & Short-Term High Return Ideas - Newser
Paradigm Health raises $78M to revamp clinical research process, inks deal with Roche's Flatiron - Fierce Biotech
100 years on, quantum mechanics is redefining reality—with us at the center
How strong is Waters Corporation stock revenue growth - Weekly Loss Report & Free Real-Time Market Sentiment Alerts - Newser
Will Waters Corporation (WAZ) stock announce a stock split - Portfolio Risk Summary & Low Drawdown Momentum Trade Ideas - Newser
Rethinking 10x Genomics (TXG): Is the Recent Share Price Rebound Already Pricing In Its Growth Potential? - Yahoo Finance
Rethinking 10x Genomics (TXG): Is the Recent Share Price Rebound Already Pricing In Its Growth Potential? - Yahoo Finance UK
Prasad's claim of 10 Covid vaccine deaths may be an overcount: FDA sources
An Arch-backed biotech raises $53M to fight neurodegeneration
Molecular Cytogenetics Market Intelligence Report (2020-2030) Featuring Key Players Danaher, MetaSystems, Agilent Technologies, Abbott Labs, Bio-Rad Labs and More - ResearchAndMarkets.com - The AI Journal
Appointments and advancements for Dec. 4, 2025
Financings for Dec. 4, 2025